Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 6,287 | 6,101 | 5,261 | 4,243 | 4,140 |
| Cost of Goods | 3,806 | 3,631 | 3,333 | 2,824 | 2,617 |
| Gross Profit | 2,482 | 2,471 | 1,928 | 1,419 | 1,523 |
| Operating Expenses | 3,110 | 3,285 | 3,167 | 3,347 | 2,787 |
| Operating Income | 177 | -184 | -906 | -1,104 | -647 |
| Interest Expense | 182 | 132 | 120 | 100 | 12 |
| Other Income | 1 | 1 | 1 | -24 | 0 |
| Pre-tax Income | -4 | -315 | -1,026 | -1,227 | -660 |
| Net Income Continuous | -4 | -315 | -1,026 | -1,227 | -660 |
| Net Income | $-4 | $-315 | $-1,026 | $-1,227 | $-660 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.03 | 0.00 | -0.03 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.03 | -0.03 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.03 | 0.00 | -0.03 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.03 | -0.03 | -0.02 |
| EBITDA(a) | $261 | $-103 | $-829 | $-1,056 | $-583 |